Adam Inglis

Xynomic Pharmaceuticals Holdings, Inc. is a clinical stage best-in-class oncology therapeutics biopharmaceutical company. It engages in licensing, developing and commercializing oncology drug candidates in China, US, and rest of the world. Its current pipeline mainly consists of 3 drug candidates; Xynomic owns global exclusive development, manufacturing and commercialization rights to each of these. Its lead drug candidate abexinostat is in global potentially pivotal clinical trials against renal cell carcinoma and non-Hodgkin's lymphoma. The company was founded by Yinglin Mark Xu on October 7, 2016 and is headquartered in Shanghai, China.

Beacon Health Options, Inc. provides behavioral health solutions. It offers its services to large regional and specialty health plans, employers and labor organizations of all sizes, as well as federal, state and local governments. The company was founded in 2014 and is headquartered in Boston, MA.

Provant Health Solutions LLC provides remote and onsite workplace wellness solutions for employees. The firm offers biometric screenings, health assessment, seasonal flu clinic, health coaching, advocacy, lifestyle management, and incentive program management services. The company was founded in 2001 and is headquartered in East Greenwich, RI.